For BPC-157 to move from experimental to evidence-based, the research community would need: Phase I (Safety) 50-100 healthy volunteers Multiple dose levels Comprehensive pharmacokinetic profiling Adverse event monitoring for 4-8 weeks minimum Phase II (Efficacy Signals) 100-300 patients with specific conditions Randomized, placebo-controlled design Validated outcome measures 3-6 month follow-up minimum Phase III (Confirmatory) 500-3000 patients Multi-site trials Long-term safety monitoring Comparison to existing treatments Currently, were stuck before Phase I even completes
(Etiology) The exact cause of Penile Melanotic Macules is not well-understood
Contents: 5 mg lyophilized (freeze-dried) powder provided in a 3 ml vial, sealed and sterile
However, it is highly specific and selective in comparison to adsorption chromatography
Having this new option provides physicians with a tool that will help prevent the life-changing amputation of ones frostbitten fingers or toes, said Norman Stockbridge, director of the Division of Cardiology and Nephrology at the FDAs Center for Drugs and Evaluation Research, in a statement
Does l-carnitine help prevent hepatic lipidosis in cats